PTPN2 deletion enhances T cell-mediated immune surveillance to prevent the formation of hematologic and solid malignancies that otherwise occur in aged mice heterozygous for the tumor suppressor p53 and also enhances the anti-tumor activity of adoptively transferred T cells, including chimeric antigen receptor (CAR) T cells14. This evidence concerns the gene PTPN2 and neoplasm.